Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumors with high-frequency microsatellite instability

被引:29
作者
Fernández-Peralta, AM
Nejda, N
Oliart, S
Medina, V
Azcoita, MM
González-Aguilera, JJ
机构
[1] Univ Autonoma Madrid, Dept Biol, Unidad Genet, E-28049 Madrid, Spain
[2] Hosp Cent Cruz Roja San Jose & Santa Adela, Serv Cirugia, Madrid 28003, Spain
[3] Hosp Univ La Laguna, Serv Cirugia, Tenerife 38071, Spain
[4] Hosp Univ Getafe, Serv Cirugia Gen & Digest, Madrid 28905, Spain
关键词
D O I
10.1016/j.cancergencyto.2004.05.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mutator pathway implied in the development of colorectal cancer is characterized by microsatellite instability (NISI), which is determined by alterations of mismatch repair (MMR) genes. Defects in MMR genes affect repetitive DNA tracts interspersed mostly between coding sequences, and therefore it cannot be expected that they play a role during tumor progression. Genes containing repetitive sequences within their coding regions could be targets for MSI tumorigenesis, but this does not necessarily imply a causal role for the affected gene, because most are probably passenger mutations. We analyzed MSI and TGFBR2 and BAX frameshift mutations to further clarify the relationships between inactivation of the two genes and genomic instability in sporadic colorectal cancer (CRC), and to address how mutations in these genes influence the development of tumors and, eventually, patient outcome. One hundred and fifty-five patients with sporadic CRC were classified according to their NISI status. Frameshift mutations in the two genes were recurrent in high-frequency NISI (NISI-H) tumors, but these tended to be more common in poorly differentiated tumors. A high rate of mutations of TGFBR2 was found in tumors at Dukes' B stage, showing a greater extent of vascular invasion. Finally, in MSI-H tumors, mutations of either gene were associated with a significant decrease in survival. Our results contribute to the understanding of how the TGFBR2 and BAX gene mutations contribute to tumor progression in the mutator phenotype pathway for MSI colorectal cancers. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 27 条
[1]   CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].
AALTONEN, LA ;
PELTOMAKI, P ;
LEACH, FS ;
SISTONEN, P ;
PYLKKANEN, L ;
MECKLIN, JP ;
JARVINEN, H ;
POWELL, SM ;
JEN, J ;
HAMILTON, SR ;
PETERSEN, GM ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A .
SCIENCE, 1993, 260 (5109) :812-816
[2]  
Akiyama Y, 1996, CANCER-AM CANCER SOC, V78, P2478, DOI 10.1002/(SICI)1097-0142(19961215)78:12<2478::AID-CNCR5>3.0.CO
[3]  
2-G
[4]   Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer [J].
Akiyama, Y ;
Iwanaga, R ;
Saitoh, K ;
Shiba, K ;
Ushio, K ;
Ikeda, E ;
Iwama, T ;
Nomizu, T ;
Yuasa, Y .
GASTROENTEROLOGY, 1997, 112 (01) :33-39
[5]  
Boland CR, 1998, CANCER RES, V58, P5248
[6]  
Duval A, 2002, CANCER RES, V62, P2447
[7]   THE HUMAN MUTATOR GENE HOMOLOG MSH2 AND ITS ASSOCIATION WITH HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
FISHEL, R ;
LESCOE, MK ;
RAO, MRS ;
COPELAND, NG ;
JENKINS, NA ;
GARBER, J ;
KANE, M ;
KOLODNER, R .
CELL, 1993, 75 (05) :1027-1038
[8]   Simultaneous mutations in K-ras and TP53 are indicative of poor prognosis in sporadic colorectal cancer [J].
González-Aguilera, JJ ;
Oliart, S ;
Azcoita, MM ;
Fernández-Peralta, AM .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (01) :39-45
[9]   Genetic alterations and MSI status in primary, synchronous, and metachronous tumors in a family with hereditary nonpolyposis colorectal cancer (HNPCC) [J].
González-Aguilera, JJ ;
Nejda, N ;
Fernández, FJ ;
Medina, V ;
González-Hermoso, F ;
Barrios, Y ;
Azcoita, MM ;
Fernández-Peralta, AM .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04) :386-391
[10]  
Grady WM, 1998, CANCER RES, V58, P3101